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70 The Journal of Thoracic and Cardiobjectives: To assess the clinical condition at mid-to-late follow-up in tetralogy of
allot corrected by a transatrial–transpulmonary approach at a young age and to
dentify risk factors associated with right ventricular dilation/dysfunction and with
ecreased exercise tolerance.
ethods: Patients with tetralogy of Fallot underwent cardiac magnetic resonance
maging, maximal bicycle ergometry, electrocardiography, Holter monitoring, and
pirometry. Multivariate linear regression analyses were used to determine inde-
endent predictors for selected clinical parameters.
esults: Fifty-nine patients (mean  SD), age at repair 0.9  0.5 years, interval
ince repair 14  5 years, were included. The median pulmonary regurgitant
raction was 32% (0%-57%). Compared with published data on healthy controls,
allot patients had significantly larger right ventricular end-diastolic and end-
ystolic volumes and smaller right ventricular and left ventricular ejection fractions.
aximum oxygen consumption was 97%  17% and maximum workload 89% 
3% of predicted. Median QRS duration was 110 ms (82–161 ms). No important
entricular arrhythmias were found. Compared with patients without a transannular
atch, patients with a patch had more pulmonary regurgitation, a larger right
entricle, worse right ventricular and left ventricular ejection fractions, but compa-
able exercise capacity. Multivariate regression analysis identified the following
ndependent determinants for larger right ventricular volumes: longer interval since
epair, longer QRS duration, and higher pulmonary regurgitation percentage. The
ollowing were independent determinants for smaller right ventricular ejection
raction: abnormal right ventricular outflow tract wall motion, longer interval since
epair, and longer QRS duration. For smaller maximum oxygen consumption, the
ndependent determinants were smaller right ventricular ejection fraction and longer
RS duration.
onclusions: At mid-to-late follow-up, clinical condition in tetralogy of Fallot
orrected according to contemporary surgical approaches appears well preserved.
owever, even these patients show right ventricular dilation and dysfunction
ssociated with impaired functional capacity. Abnormalities relate to right ventric-
lar outflow tract motion abnormalities, longer interval since repair, longer QRS
uration, and more severe pulmonary regurgitation.
ver the past decades, perioperative mortality of correction for tetralogy of
Fallot (TOF) decreased for all ages, including infants.1,2 Repair at a young
age shortens the period the patient is subjected to systemic hypoxemia and
o right ventricular (RV) pressure overload. These considerations have led to a trend
f primary correction performed at a young age, aimed at optimal relief of RV
utflow tract (RVOT) obstruction and closure of the VSD.1,2 In addition, the
vascular Surgery ● February 2007
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Doncept of transatrial–transpulmonary repair for TOF
ained popularity.3 This concept aims at reducing the side
ffects associated with a ventriculotomy, such as RV myo-
ardial and coronary artery damage. Outcome of TOF repair
as been described extensively. Pulmonary regurgitation
PR) is a crucial factor in long-term outcome.4 There is a
ack of studies reporting on long-term follow-up, acquired
ith appropriate tools, in patients with TOF repaired ac-
ording to recent surgical strategies. Furthermore, most
tudies have included a mixture of patients with optimal and
uboptimal surgical results, such as residual VSD or impor-
ant pulmonary stenosis. This precludes assessment of op-
imal long-term effects of repair of TOF and of factors
ssociated with decline in clinical state after optimal repair,
hat is, clinical condition in patients with (inevitable) PR,
ut without additional problems. Therefore, the present
tudy aimed (1) to assess clinical condition at midterm to
ong-term follow-up, including assessment of biventricular
olumes and function by cardiac magnetic resonance imag-
ng (CMR) and (2) to identify factors associated with RV
ilation, RV dysfunction, and decreased exercise tolerance
n patients with TOF operated on at a young age by the
ransatrial–transpulmonary approach and without residual
SD or important pulmonary stenosis.
atients and Methods
cross-sectional study of patients after surgical repair of TOF was
erformed. The local medical ethics committee approved our study
rotocol. Informed consent was obtained from patients or parents
f patients were not of the legal age to provide consent. Patients
ere included for data collection between September 2002 and
ovember 2004. The following inclusion criteria were used: (1)
omplete repair of TOF without associated cardiac lesions, includ-
ng double-outlet right ventricle (except patent ductus arteriosus),
2) age at repair 24 months years or younger, (3) transatrial–
ranspulmonary approach to repair, and (4) duration of postrepair
ollow-up of 5 years or more. Patients with one or more of the
ollowing criteria were excluded: residual VSD, residual pulmo-
ary stenosis (echo Doppler mean gradient  30 mm Hg), repair
Abbreviations and Acronyms
CMR  cardiac magnetic resonance imaging
FVC  forced vital capacity
LV  left ventricular
PR  pulmonary regurgitation
RQ  respiratory quotient
RV  right ventricular
TAP  transannular patch
TE  echo time
TOF  tetralogy of Fallot
VO2max maximum oxygen consumption
VSD  ventricular septal defectith a homograft, mental retardation, and known extracardiac c
The Journal of Thoracicathologic condition. Criteria were reviewed by use of the pa-
ient’s medical records. Preoperative hemodynamic data were ob-
ained from diagnostic heart catheterization reports.
agnetic Resonance Imaging Protocol
1.5-Tesla Signa CVi scanner was used with software releases V8
nd V9.1 (General Electric, Milwaukee, Wis). A cine volumetric
ataset was acquired in short-axis direction using a 2-dimensional
ast imaging employing steady-state acquisition sequence (steady-
tate free precession). Imaging parameters were as follows: flip
ngle  45°, echo time (TE) set at minutes full, repetition time
TR)  3.4–3.6 ms, 8-to 9-mm slice thickness, 0- to 1-mm
nterslice gap, 12 views/segment, readout bandwidth  111 KHz,
square field of vision (30–34 cm), and a scanning matrix of 160
128. Twenty-four phases per cardiac cycle were reconstructed
etrospectively.
Pulmonary valve flow measurements were performed perpen-
icular to flow using a standard 2-dimensional retrospectively
ated flow-sensitized sequence. Thirty cardiac phases were recon-
tructed retrospectively. Imaging parameters were as follows:
-dimensional fast spoiled gradient echo, TR  6 to 7 ms, TE 
ms, flip angle  20o, readout bandwidth  90 KHz, 6-mm slice
hickness, 6 views/segment, a rectangular field of vision (75% in
hase encoding direction), and a scanning matrix of 256 · 128.
agnetic Resonance Image Analysis
MR studies were analyzed on an Advanced Windows worksta-
ion (General Electric, Milwaukee, Wis). Flow images were quan-
itatively analyzed with the Flow analysis software package V2.0
Medis Medical Imaging Systems, Leiden, The Netherlands). Re-
idual pulmonary stenosis was calculated with the simplified Ber-
oulli equation (P  4 · Vmax2). Volumetric data were quanti-
atively analyzed with the Mass analysis software package V3.1
Medis Medical Imaging Systems, Leiden, The Netherlands), with
arameters assessed according to analysis techniques widely re-
orted in the literature.5 Volumetric CMR parameters were in-
exed for body surface area unless specified otherwise. Values
utside the mean 2 SD range in healthy controls were defined to
e abnormal. On the cines an experienced observer assessed wall
otion in the RVOT. Abnormal wall motion was defined as absent
r outward movement of part of the RVOT wall during systole. To
alculate the PR fraction, amount of PR was normalized for the
ystolic stroke volume across the pulmonary valve (PR percentage
 Backward flow/Systolic forward flow · 100%). Critical upper
imits for RV end-diastolic volume, 200 mL/m2 in children and
70 mL/m2 in adults, associated with absent return of RV volume
o normal size after pulmonary valve replacement have been
eported and were applied on our population.6,7
icycle Ergometry
atients performed a symptom-limited bicycle exercise test on a
aëger Oxycom Champion System (Viasys Healthcare, Hoech-
erg, Germany), allowing breath-by-breath-ergometry. Workload
as increased with 10 to 20 Watts per minute. Patients were
ncouraged to perform to exhaustion. Tests were regarded as
aximal with a respiratory quotient (RQ) of 1.05 or greater in
hildren and 1.10 or greater in adults at peak exercise. Exercise
apacity was compared with that of normal individuals, corrected
and Cardiovascular Surgery ● Volume 133, Number 2 471
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Dor age, sex, and weight.8 Values greater than 85% of predicted
ere considered normal.
pirometry
receding the exercise test, patients performed a standard maximal
orced vital capacity (FVC) maneuver using a dry rolling seal
pirometer (Jaëger, Würzburg, Germany). From the obtained loops
he following parameters were derived: FVC, forced expiratory
olume in the first second (FEV1), ratio FEV1/FVC, and maximum
xpiratory flow at 25% of FVC. Results were compared with those
rom normal individuals corrected for age, gender, and body
omposition and expressed as percentages of predicted values.
lectrocardiogram
standardized 12-lead electrocardiogram was obtained to assess
RS (ms), QT corrected for heart rate (QTc; ms), and JT corrected
or heart rate (JTc; ms) duration. A 24-hour Holter monitoring was
erformed on a day with usual activities.
tatistical Analysis
MR results of patients were compared with a reference popula-
ion from the literature using the 2-sample t test.9 Data were
og10-transformed when appropriate to obtain approximately nor-
al distribution. Results are expressed as mean SD for normally
istributed data, otherwise as the median and range. Bivariate
orrelation coefficients were calculated by the Spearman method.
ultivariate linear regression analyses (backward stepwise regres-
ion method) were used to determine major independent predictors
or outcome variables. Only variables significant in univariate
nalysis were included in these multivariate analyses. Percentages
ere compared by the 2 test. Analysis was performed with the
PSS-PC statistical software package version 11.5 (SPSS, Chi-
ago, Ill).
esults
atient Characteristics
ecords of 169 eligible patients alive in 2002 and operated
n between 1980 and 1997 before the age of 2 years by a
ransatrial–transpulmonary approach at the Erasmus MC
otterdam or the University MC Utrecht were checked.
easons for exclusion were as follows: residual VSD (n 
), residual RVOT stenosis (30 mm Hg) (n  11), repair
ith a homograft (n  15), mental retardation (n  16),
xtracardiac disease (n 7), and lost to follow-up (n 32).
ighty-five patients fulfilled all inclusion criteria and re-
eived an invitation for this study. Sixty-three (74%) pa-
ients agreed to participate. Four of our youngest partici-
ants (aged 5.9–6.5 years) did not complete the entire
rotocol and were excluded from all results. The character-
stics of the remaining 59 patients are shown in Table 1.
atients who refused to participate and those lost to fol-
ow-up did not differ from participants in mean age at
epair, interval since repair, incidence of staged repairs, or
ender distribution. Patients did not use cardiac medication,
1 (86%) were in New York Heart Association class I
86%), and 8 (14%) in class II. 6
72 The Journal of Thoracic and Cardiovascular Surgery ● FebrIn 42 (71%) patients a transannular patch (TAP) repair
as performed. In the remaining 17 (29%) patients desob-
truction of the RVOT was achieved by a combination of
he following techniques: infundibulectomy, valvulotomy,
ommissurotomy, and partial valvectomy. Before repair,
atients with a TAP had a lower arterial oxygen saturation
86% 9% vs 92% 9%; P .05) and a higher RV/aortic
eak pressure ratio (1.0  0.1 vs 0.9  0.1; P  .05) than
id patients without a TAP. TAP repairs were performed at
younger age (median age at repair 0.6 years [0.2–2.0
ears] versus 1.1 [range 0.3–2.0]; P  .05). Interval since
epair was comparable between patients with a TAP and
hose without (15  5 years versus 13  4 years; P  .14).
MR
he median value for PR percentage was 35% (range 0%–
7%). Patient CMR data were compared with data from the
iterature assessed in healthy controls (Table 2).9 Differ-
nces in CMR findings between patients with and without a
AP are shown in Table 3. Abnormal wall motion in the
VOT region was diagnosed in 41 (69%) patients. Cumu-
ative incidence of abnormal wall motion was larger in
atients with a TAP than in those without (37/42 patients vs
/17; 2 test  .001). Similar differences as for patients
ith or without a TAP were found with regard to PR,
iventricular size, and ejection fraction when comparisons
ere made for patients with abnormal RVOT wall motion
ersus those with normal wall motion (data not shown).
The RV end-diastolic volume was greater than 170
L/m2 in 14 (24%) patients and more than 200 in 4 (7%).
ompared with patients with an RV end-diastolic volume of
70 mL/m2 or less, patients with an RV end-diastolic vol-
me greater than 170 had a smaller RV ejection fraction
50%  6% vs 44%  5%; P  .05), comparable left
entricular (LV) ejection fraction (57%  6% vs 55% 
ABLE 1. Patient characteristics
Patient total,
n  59 (100%)
ender (M/F) 41/18
ge at repair (y) 0.8 (0.2–2.0)
ge at study (y) 15 (6–23)
nterval since repair (y) 14 (6–23)
SA (m2) 1.5  0.4
revious Blalock-Taussing shunt 3 (5%)
reoperative measures
RV/aortic peak pressure ratio 1.0 0.1
RV peak pressure (mm Hg) 88 9
Oxygen saturation (%) 87 (62–100)
esidual pulmonary stenosis (mm Hg) 9 (3–29)
ata given are mean  SD and median (range). BSA, Body surface area;
V, right ventricle.%; not significant), and worse exercise capacity (percent-
uary 2007
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Dge of predicted maximum (peak) oxygen consumption
VO2max] 99%  18% vs 90%  11%; P  .05). All
atients with RV end-diastolic volume greater than170
L/m2 had 12 years or more of follow-up (median 18 years,
ange 12–23) and a PR percentage greater than 30% (me-
ian 46%, range 31%–54%).
ABLE 2. Biventricular CMR results in patients and contro
TOF patients
o. of patients 59
ge (y) 15  5
Mean SD Range
VEDV (mL/m2) 139 37* 85–237
VESV (mL/m2) 72  26* 35–145
VSV (mL/m2) 66  14* 36–100
VEF (%) 49 6* 32–60
VEDV (mL/m2) 81  12 61–109
VESV (mL/m2) 36  8* 16–53
VSV (mL/m2) 46  7 31–67
VEF (%) 56 6* 42–74
imits of normal: UL (upper limit)  mean  2 SD; LL (lower limit)  mea
VEDV, right ventricular end-diastolic volume; RVESV, right ventricular end
jection fraction; LVEDV, left ventricular end-diastolic volume; LVESV, left
entricular ejection fraction; SD, standard deviation. *Significant differenc
esults (above UL or below LL of relevance).
ABLE 3. Comparison of patients according to presence of
TAP in the RVOT*
No patch,
n  17 (29%)
TAP repair,
n  42 (71%)
R percentage 14 12 40  11†
esidual pulmonary stenosis 13 7 9  6†
VEDV (mL/m2) 106 19 152  35†
VESV (mL/m2) 51  12 81  25†
VSV (mL/m2) 55  10 71 13†
VEF (%) 52  6 47  6†
VFWM (g/m2) 20  4 26  6†
VEDV (mL/m2) 82  12 81  12
VESV (mL/m2) 34  8 37  8
VSV (mL/m2) 48  8 45 7
VEF (%) 59  6 55  5†
VM (g/m2) 52  9 53  10
ata given are mean  SD. TAP, Transannular patch; RVOT, right ventric-
lar outflow tract; PR, pulmonary regurgitation; RVEDV, right ventricular
nd-diastolic volume; RVESV, right ventricular end-systolic volume; RVSV,
ight ventricular stroke volume; RVEF, right ventricular ejection fraction;
VFWM, right ventricular free wall mass; LVEDV, left ventricular end-
iastolic volume; LVESV, left ventricular end-systolic volume; LVSV, left
entricular stroke volume; LVEF, left ventricular ejection fraction; LVM, left
entricular mass. All CMR parameters were indexed for body surface area.
Similar differences with regard to PR, biventricular size, wall mass and EF
ere found when comparisons were made for patients with normal and
bnormal RVOT wall-motion (data not shown). †Significant difference
pompared with patients without a patch in the RVOT (t test, P  .05)
The Journal of Thoraciclectrocardiogram and Holter Monitoring
ll patients were in sinus rhythm. Right bundle branch
lock was diagnosed in 80% of patients. Median QRS
uration was 110 ms (range 82–161 ms), mean QTc dura-
ion was 408  32 ms, and mean JTc duration was 270 
3 ms. No differences were found for QRS duration (P 
47), QTc duration (P .39), and JTc duration (P  0.26)
etween patients with or without a TAP.
During 24-hour Holter monitoring, 5 patients showed
ne or more cardiac pauses of more than 1.9 second. The
ongest observed pause lasted 2.3 seconds. Two patients,
oth with a TAP, showed a nonsustained ventricular tachy-
ardia run of respectively 3 and 4 complexes at heart rates
f 174 and 108 beats/min with a QRS duration in sinus
hythm of 105 and 130 ms, respectively.
pirometry
ean FEV1 was 99%  12% of predicted. Mean FVC was
4%  12% of predicted. The median FEV1/FVC ratio was
9% (range 75%–100%). Mean maximum expiratory flow
t 25% of FVC was 89%  31% of predicted. Mean FVC
f predicted tended to be higher in patients without a TAP
97%  14% vs 90%  12%; P  .05). The other param-
ters were not different between patients with and without a
AP.
One patient showed severe obstructive abnormalities,
nd exercise results of this patient were excluded from
nalysis. The parameters derived from the maximal flow-
olume loops showed no significant correlations with per-
entage of predicted VO2max.
icycle Ergometry
he patient with obstructive airway disease was excluded, 1
Controls Abnormal†
16
18 2
Mean SD Limit N (%)
79 9 97 (UL) 50 (85%)
32 7 56 (UL) 50 (85%)
49 6 61 (UL) 38 (64%)
61  6 49 (LL) 29 (49%)
79 9 97 (UL) 7 (12%)
29  7 43 (UL) 10 (17%)
49  6 37 (LL) 4 (7%)
63  6 51 (LL) 7 (12%)
SD. CMR, Cardiac magnetic resonance imaging; TOF, tetralogy of Fallot;
olic volume; RVSV, right ventricular stroke volume; RVEF, right ventricular
cular end-systolic volume; LVSV, left ventricular stroke volume; LVEF, left
 .05) compared with controls. †Number of patients with abnormal CMRls
n  2
-syst
ventri
e (Patient declined the test, and 1 patient could not complete
and Cardiovascular Surgery ● Volume 133, Number 2 473
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Dhe test as a result of technical problems. Exercise data
eflect results of the remaining 56 patients. Mean RQ at
eak exercise was 1.2  0.1. All patients reached our RQ
riteria at peak exercise. Age at study correlated positively
ith RQ at peak exercise (r  0.44; P  .001) and RQ
uring initial recovery (r  0.69; P  .001). VO2max was 40
8 mL · kg1 · min1, or 97% 17% of predicted VO2max
P  .20), with a value less than 85% found in 14 (25%)
atients. Mean peak workload was 149  62 Watts, or 89%
13% of predicted (P  .05), with value less than 85%
ound in 18 (32%) patients.
Percentage of predicted workload and percentage of pre-
icted VO2max were not different between patients with a
AP and those without a TAP (respectively, 88% 11% vs
2%  17%; P  .37; and 96%  15% vs 99%  22%; P
.59). Percentage of predicted workload and percentage of
redicted VO2max were smaller in patients with abnormal
VOT wall motion than in patients with normal motion
respectively, 86%  12% vs 95%  13%; P  .05; and
4%  16% vs 103%  19%; P  .07).
eterminants of Exercise Capacity
actors significantly related to VO2max and percentage of
redicted VO2max by univariate analysis were determined.
ABLE 4. Predictors of peak oxygen consumption (VO2)
Univar
redictor Regression coeffici
ependent: VO2 (mL · kg
1 · min1)
VSV (mL/m2) 0.5  0.
ender (M/F) 7.0  2.
nterval since repair (y) 0.6  0.
RS duration (ms) 0.15 0.
Constant
VEF (%) 0.53 0.
R percentage 0.17 0.
AP (yes/no) 4.8 2.
VOT motion (abnormal/normal) 5.3  2.
V peak pressure (mm Hg) 0.18 0.
ependent: VO2 percentage of predicted
VEF (%) 1.6 0.
RS duration (ms) 0.4  0.
Constant
VESV (mL/m2) 0.23 0.
VSV (mL/m2) 0.8  0.
VEF (%) 1.2 0.
nterval since repair (y) 1.5  0.
V peak pressure (mm Hg) 0.39 0.
ata given are regression coefficients  standard errors. R2 for the multipl
ere respectively 0.49 and 0.36.
VSV, Left ventricular stroke volume; RVEF, right ventricular ejection fractio
utflow tract; RV, right ventricular; RVESV, right ventricular end-systolic vol
S, not significant.redictor variables originated from the following 3 sets of y
74 The Journal of Thoracic and Cardiovascular Surgery ● Febrarameters: (1) parameters determined at prerepair diagnos-
ic heart catheterization (RV peak pressure, arterial oxygen
aturation, RV/aortic pressure ratio), (2) perioperative pa-
ameters (age at repair, TAP [0 present, 1 absent]), and
3) postoperative parameters (PR percentage, interval since
epair, RVOT wall motion [0  abnormal, 1  normal],
RS duration, QTc, JTc, and all biventricular CMR deter-
ined measures).
Variables with significant relations (at the .05 level)
dentified by univariate analysis were used in multiple re-
ression analysis to identify independent determinants. Re-
ults for both the univariate and multivariate linear regres-
ion analyses are shown in Table 4.
eterminants of RV CMR Measures and PR
ercentage
V CMR parameters and PR percentage were analyzed by
he same procedures described in the previous paragraph.
uring analyses on RV end-diastolic volume, end-systolic
olume, and ejection fraction, the corresponding LV param-
ter was introduced in the model. Mathematically related
V CMR measures were not used in one model. Results for
oth the univariate and multivariate linear regression anal-
nalysis Multivariate analysis
SE P value Regression coefficient  SE P value
.002 0.4 0.1 .001
.002 5.9  1.8 .002
.004 0.5  0.2 .004
.008 0.10 0.05 .04
34.9 7.5 —
.002 NS
.009 NS
.04 NS
.02 NS
.03 NS
.001 1.3 0.3 .001
.001 0.2  0.1 .05
59.4 24.1 —
.009 NS
.02 NS
.002 NS
.001 NS
.02 NS
ression model of VO2 (mL · kg
1 · min1) and VO2 (percentage of predicted)
, pulmonary regurgitation; TAP, transannular patch; RVOT, right ventricular
VSV, left ventricular stroke volume; LVEF, left ventricular ejection fraction;iate a
ent 
2
2
2
06
16
06
2
2
08
3
1
09
3
4
4
16
e reg
n; PR
ume; Lses are shown in Table 5.
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Discussion
his study provides quantitative data on clinical status at
id-to-late follow-up in patients with TOF corrected at a
elatively young age by a transatrial–transpulmonary ap-
roach and without other residual lesions but PR. TOF
epair almost inevitably results in some degree of PR. Here
he median PR percentage was 35% (range 0%–57%). As
xpected with considerable volume overload, RV volumes
ere markedly elevated in our patients, with mean values
eing approximately twice that in controls and values above
he upper limit of normal found in 85% of our patients
Table 2). Furthermore, RV and LV ejection fractions were
ecreased compared with controls in, respectively, 49% and
ABLE 5. Predictors of RV CMR measures
Univariate a
redictor Regression coefficient 
ependent: RVEDV (mL/m2)
nterval since repair (y) 3.7 0.9
R percentage (%) 1.5 0.2
VEDV (mL/m2) 1.3  0.4
Constant
AP (yes/no) 42 9
VOT motion (abnormal/normal) 7 9
V peak pressure (mm Hg) 1.0 0.3
ependent: Log10 RVESV (mL/m
2)
nterval (y) 0.016 0.003
R percentage 0.006 0.001
VESV (mL/m2) 0.009 0.002
RS duration (ms) 0.003 0.001
Constant
V peak pressure (mm Hg) 0.004 0.001
AP (yes/no) 0.17 0.04
ependent: RVEF (%)
nterval (y) 0.59 0.14
RS duration (ms) 0.12 0.04
VEF (%) 0.49 0.13
VOT motion (abnormal/normal) 5.9 1.6
Constant
V peak pressure (mm Hg) 0.13 0.06
R percentage 0.12 0.05
AP (yes/no) 4.7  1.7
ependent: PR percentage
AP (yes/no) 22.5 3.4
V peak presssure (mm Hg) 0.39 0.14
Constant
VOT motion (abnormal/normal) 17.9 4.0
rterial oxygen saturation 0.57 0.21
nterval since repair (y) 0.83 0.41
V free wall mass (g/m2) 1.1  0.3
ata given are regression coefficients  standard errors. R2 for the m
espectively 0.76, 0.72, 0.53 and 0.53. RV, Right ventricular; CMR, cardiac m
ulmonary regurgitation; LVEDV, left ventricular end-diastolic volume; T
entricular ejection fraction; RVOT, right ventricular outflow tract; LVESV,2% of our patients. Despite these striking abnormalities, w
The Journal of Thoracichronic RV volume overload seems to be well tolerated by
hese patients. All were in New York Heart Association
lass I (86%) or II (14%), all were in sinus rhythm, and none
sed cardiac medication. Mean percentage of predicted
O2max was not different from controls. Patients had normal
ung function, and no important ventricular arrhythmias
ere encountered.
This study identified independent predictors of several
ndesirable, but common problems during the follow-up of
OF. The most important predictor of poorer exercise ca-
acity was a lower RV ejection fraction, which in turn was
est predicted by abnormal RVOT wall motion. Larger RV
ilation and poorer RV ejection fraction were associated
is Multivariate analysis
P value Regression coefficient  SE P value
.001 1.4 0.6 .05
.001 1.3 0.2 .001
.001 1.5  0.2 .001
54.8 18.4 —
.001 NS
.001 NS
.005 NS
.001 0.007 0.003 .01
.001 0.005 0.001 .001
.001 0.007 0.002 .001
.02 0.001  0.001 .05
1.15 0.09 —
.003 NS
.001 NS
.001 0.3  0.1 .05
.007 0.07 0.03 .05
.03 0.5  0.1 .001
.001 3.1  1.4 .05
39.1 7.0 —
.03 NS
.03 NS
.007 NS
.001 22.2 3.3 .001
.008 0.3  0.1 .02
5.7  9.0 —
.001 NS
.01 NS
.05 NS
.001 NS
regression models of RVEDV, RVESV, RVEF and PR percentage were
tic resonance imaging; RVEDV, right ventricular end-diastolic volume; PR,
ransannular patch; RVEF, right ventricular ejection fraction; LVEF, left
entricular end-systolic volume; LVEF, left ventricular ejection fraction.nalys
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ultiple
agne
AP, tith a longer interval since repair. This suggests that, even
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4
CH
Dn patients with TOF corrected according to current surgical
trategies and with optimal surgical result, gradual but slow
eterioration of RV function with volume overload seems
nevitable. Patients with already marked RV dilation sub-
ected to chronic PR may have symptoms develop over
ime, which stresses the need for serial follow-up.
VOT Function in Repaired TOF
revious studies have demonstrated the negative impact of
AP repair on PR and RV size.10 In our study, multivariate
egression analysis showed that TAP repair was the most
mportant independent predictor of PR percentage, with a
2%  3% point higher PR percentage in patients with a
AP than in those without a TAP (Table 5). A higher PR
ercentage independently predicted larger RV volumes, but
ot poorer RV ejection fraction. Poorer RV ejection fraction
as independently predicted by abnormal RVOT wall mo-
ion. A previous study among adult Fallot patients, operated
n at older ages than our patients, also found abnormal
otion in the RVOT region to predispose for RV dysfunc-
ion.10 Both that study and ours showed that abnormal wall
otion is not restricted to patients with a TAP. This sug-
ests wall motion abnormalities can be induced by other
actors. Remarkably, Davlouros and associates10 found no
ifference in incidence of wall motion abnormalities be-
ween patients with and without TAP, whereas this differ-
nce was clearly present in our patients. This may be
xplained by the different primary surgical approach used,
ith a primary ventriculotomy used in most of the cases
eported by Davlouros’ group.10 However, other factors
uch as prolonged hypoxemia, present in the cases reported
y Davlouros and colleagues,10 cannot be ruled out to play
role in RV wall motion abnormalities. The influence of
urgery in the RVOT region on long-term outcome has also
een studied by comparing patients undergoing transven-
ricular TOF repair with patients with isolated pulmonary
alve stenosis treated by pulmonary commissurotomy.11
reedom of adverse events related to RV dilation (defined
s cardiac death, reoperation, and New York Heart Associ-
tion class  II) was better in patients after isolated com-
issurotomy despite similar degrees of moderate and severe
R found in both patient groups. These findings suggest that
imited RVOT surgery contributes to better long-term out-
ome, which is supported by our study. Whether or not the
ecently described reconstructive technique of the pulmo-
ary valve by Sung and colleagues12 further contributes
o improved outcome remains a matter of ongoing
bservation.
RS Duration
n TOF a QRS duration greater than 180 ms in adults and
reater than 170 ms in children is known to predispose to
alignant ventricular arrhythmia and sudden death.13,14 o
76 The Journal of Thoracic and Cardiovascular Surgery ● FebrRS duration did not exceed 170 ms in our patients. Re-
idual PR and subsequent RV dilation have been associated
ith QRS prolongation.14-16 Pulmonary valve replacement
as been shown to reduce QRS duration proportionally to
he degree of RV volume reduction.17,18 In our population,
RS duration was an independent predictor of RV volume
ut also of RV ejection fraction and exercise tolerance
Table 5). These predictive effects were present in the range
elow the reported critical values that predispose for ar-
hythmia and sudden death.
Prolongation of QRS duration has been related to elec-
rical inhomogeneity.19 In this regard, ventricular dyssyn-
hrony has been observed in TOF. Cardiac resynchroniza-
ion therapy in heart failure with prolonged QRS duration
as been proven beneficial for ventricular contractile func-
ion, symptomatic status, and mortality.20,21 Thus far, re-
ults in congenital heart disease including TOF have been
romising.19 The relations found for QRS duration with RV
jection fraction and exercise capacity in the present study
uggest that functional gain may be achieved by cardiac
esynchronization therapy in selected patients with TOF.
ong-term Outcome of TOF
ulmonary valve replacement currently is the only widely
ccepted treatment for residual PR in TOF. Optimal timing
f this procedure seems crucial, but criteria so far have not
een established.4 Newer imaging techniques, such as
MR, are expected to supply the data required to design
uch criteria. Several groups studied outcome of pulmonary
alve replacement using serial CMR data.6,7,22 An RV end-
iastolic volume of 170 mL/m2 or less in adults and 200
L/m2 or less in children was found to relate to adequate
ecovery of RV volume.6,7 Our patients with an RV end-
iastolic volume greater than 170 mL/m2 had worse exer-
ise capacity. Remarkably, all these patients had an interval
ince repair of 12 years or more and a PR percentage greater
han 30%. Patients with a PR percentage of 30% or less did
ot demonstrate an RV end-diastolic volume of more than
70 mL/m2, irrespective of follow-up duration. Most large
MR-based studies report on patients with TOF operated on
ccording to different surgical strategies than our patients
older age at repair, staged repairs, primary RV ventriculot-
my, repair with RV–pulmonary artery conduits).10,23 We
emonstrate that previously obtained CMR criteria also
dentify worse clinical status in patients operated on accord-
ng to a currently widely accepted surgical approach. How-
ver, the long-term prognostic value of these criteria regard-
ng mortality and morbidity still has to be determined in
atients from any surgical era.7
tudy Limitations
ecause of the potential negative effect of a ventriculotomy
n long-term clinical state, a transatrial–transpulmonary
uary 2007
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CH
Dpproach was chosen in all patients. The frequent use of a
AP illustrates that total avoidance of a ventriculotomy in
OF is not feasible in clinical practice. Furthermore, it
reated the opportunity to evaluate the effect of a TAP on
linical condition. Inclusion criteria limit this study to pa-
ients with “isolated” PR. As such, our patients represent
hat part of daily clinical practice with optimally repaired
nitial pathology (VSD and RVOT obstruction). Because of
he design, difficulties in data interpretation introduced with
arious forms of ventricular overload are avoided.
We used CMR reference values from healthy controls of
he same age range, obtained and analyzed in similar ways
s in the current study.9 During the assessment of functional
apacity, we did not account for level of physical training.
he RQ at peak exercise indicates all patients performed
aximally. As expected, results show higher RQ values in
lder patients. Therefore, peak results may better reflect
aximal exercise capacity in older patients. This may have
esulted in a slight underestimation of the magnitude of
egression in exercise capacity over time.
The debate on optimal age at repair is still ongoing. As
ll our patients had corrective surgery after the age of 2
onths, we can only speculate on further improvement of
linical state if surgical correction was done in the neonatal
eriod. We did not find important effects of age at repair on
he outcome measures shown in Tables 4 and 5.
onclusions
he current study demonstrates that at mid-to-late follow-
p, symptomatic status, exercise performance, and rhythm
tatus remain relatively normal in patients with TOF after
epair according to a transatrial–transpulmonary approach.
eterioration of RV function and exercise capacity correlate
ith a longer interval since repair, but these moderate
ssociations cannot be used to predict the pace of decline in
he individual patient. Our results suggest that further im-
rovement of clinical condition may be obtained by improv-
ng preservation of RVOT function and by reducing the
ffect of electrical inhomogeneity. The evolution of CMR,
lectrocardiographic, and exercise data in this series, as well
s the need for and the effects of interventions, should be
e-evaluated in future studies.
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